RAINBOW

RAINBOW was established with the aim of promoting the development of autologous bone marrow mesenchymal stem cell products

Number of Funding Rounds

Total Funding Amount

1

¥150M

RAINBOW has raised a total of ¥150M in funding over 2 rounds. Their latest funding was raised on Oct 26, 2020 from a Seed round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Oct 26, 2020	Seed	¥150M	2	—	—	Detail

Number of Lead Investors

Number of Investors

—

2

RAINBOW is funded by 2 investors. Hokkaido Research Institute for the Twenty-first Century and Okasan Capital Partners are the most recent investors.

Investor Name	Lead Investor	Funding Round
Hokkaido Research Institute for the Twenty-first Century	—	Seed
Okasan Capital Partners	—	Seed